In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 6, 2005, Pages 1063-1068

  Mäkinen, Tatu J ^a   Veiranto, Minna ^b   Lankinen, Petteri ^a   Moritz, Niko ^a   Jalava, Jari ^c   Törmälä, Pertti ^b   Aro, Hannu T ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Antimicrobial delivery; Bioactive glass; Osteomyelitis

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; DRUG CARRIER; FILLER; GLASS; MICROSPHERE; POLYGLACTIN; PURASORB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIODEGRADABLE IMPLANT; BONE DEFECT; BONE INFECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG BONE LEVEL; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG PELLET; ELUTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOMYELITIS; RABBIT; SURGICAL TECHNIQUE; SUSTAINED DRUG RELEASE; TIBIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BONE AND BONES; BONE SUBSTITUTES; CIPROFLOXACIN; DELAYED-ACTION PREPARATIONS; MALE; MICROBIAL SENSITIVITY TESTS; MICROSPHERES; MODELS, ANIMAL; OSTEOGENESIS; OSTEOMYELITIS; POLYGLACTIN 910; RABBITS;

EID: 29444453501     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki366     Document Type: Article

References (32)

1. Cierny G 3rd, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop 2003; 414: 7-24.
2. Simpson AH, Deakin M, Latham JM. Chronic osteomyelitis. The effect of the extent of surgical resection on infection-free survival. J Bone Joint Surg 2001; 83-B: 403-7.
3. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg 2004; 86-A: 2305-18.
4. Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg 2004; 188: 57-66.
5. Tetsworth K, Cierny G 3rd. Osteomyelitis debridement techniques. Clin Orthop 1999; 360: 87-96.
6. Nelson CL, McLaren SG, Skinner RA et al. The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res 2002; 204: 643-7.
7. Trecant M, Guicheux J, Grimandi G et al. Dynamic compaction: A new process to compact therapeutic agent-loaded calcium phosphates. Biomaterials 1997; 18: 141-5.
8. Kawanabe K, Okada Y, Matsusue Y et al. Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Joint Surg 1998; 80-B: 527-30.
9. Solberg BD, Gutow AP, Baumgaertner MR. Efficacy of gentamicin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthop Trauma 1999; 13: 102-6.
10. McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res 2004; 427: 101-6.
11. Baro M, Sanchez E, Delgado A et al. In vitro-in vivo characterization of gentamicin bone implants. J Controlled Release 2002; 83: 353-64.
12. Castro C, Sanchez E, Delgado A et al. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. J Controlled Release 2003; 93: 341-54.
13. Koort JK, Mäkinen TJ, Suokas E et al. Efficacy of ciprofloxacin releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob Agents Chemother 2005; 49: 1502-8.
14. U. S. Pharmacopoeia & the National Formulary. USP 23-NF18. Rockville, MD, USA: United States Pharmacopeial Convention, Inc., 1995.
15. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA, 2000.
16. Mäkinen TJ, Veiranto M, Knuuti J et al. Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus. Bone 2005; 36: 292-9.
17. Galanakis N, Giamarellou H, Mousses T et al. Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: Evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother 1997; 39: 241-6.
18. Mader JT, Shirtliff ME, Bergquist SC et al. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res 1999; 360: 47-65.
19. Neut D, van de Belt H, van Horn JR et al. Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation. Biomaterials 2003; 24: 1829-31.
20. Hench LL. Bioactive ceramics. Ann NY Acad Sci 1988; 523: 54-71.
21. Itälä A, Välimäki VV, Kiviranta R et al. Molecular biologic comparison on new bone formation and resorption on microrough and smooth bioactive glass microspheres. J Biomed Mater Res 2003; 65B: 163-70.
22. Stoor P, Söderling E, Grenman R. Interactions between the bioactive glass S53P4 and the atrophic rhinitis-associated microorganism Klebsialla ozaenae. J Biomed Mater Res 1999; 48: 869-74.
23. Lew DP, Waldvogel FA. Quinolones and osteomyelitis: State-of-the-art. Drugs 1995; 49: 100-11.
24. Miclau T, Edin ML, Lester GE et al. Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro. J Orthop Res 1998; 16: 509-12.
25. Holtom PD, Pavkovic SA, Bravos PD et al. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 2000; 18: 721-7.
26. Huddleston PM, Steckelberg JM, Hanssen AD et al. Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg 2000; 82-A: 161-73.
27. Perry AC, Prpa B, Rouse MS et al. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res 2003; 414: 95-100.
28. Isefuku S, Joyner CJ, Simpson AH. Toxic effect of rifampicin on human osteoblast-like cells. J Orthop Res 2001; 19: 950-4.
29. Isefuku S, Joyner CJ, Simpson AH. Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma 2003; 17: 212-6.
30. Edin ML, Miclau T, Lester GE et al. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 1996; 333: 245-51.
31. Haleem AA, Rouse MS, Lewallan DG et al. Gentamicin and vancomycin do not impair experimental fracture healing. Clin Orthop Relat Res 2004; 427: 22-4.
32. Nungu KS, Larsson S, Wallinder L et al. Bone and wound fluid concentrations of cephalosporins. Oral cefadroxil and parenteral cefuroxime compared in 52 patients with a trochanteric fracture. Acta Orthop Scand 1995; 66: 161-5.